Gene Editing & CRISPR in Cancer

Gene editing, especially CRISPR-Cas9, is revolutionizing cancer research and treatment by enabling precise modifications of cancer-related genes. This breakthrough technology allows scientists to correct genetic mutations, enhance immune cell function, and develop targeted therapies with greater accuracy. CRISPR is being explored for its potential in disrupting oncogenes, boosting tumor-suppressor genes, and engineering CAR-T cells for more effective immunotherapy. As clinical trials advance, CRISPR holds promise for personalized cancer treatments, offering a new era of precision medicine with fewer side effects and improved patient outcomes.

    Related Conference of Gene Editing & CRISPR in Cancer

    April 28-29, 2025

    35th Experts Meet On Cancer Research & Therapy

    Paris, France
    May 26-27, 2025

    15th World Congress on Breast Cancer

    Rome, Italy
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Paris, France
    August 18-19, 2025

    6th Cancer Diagnostics & Treatment Conference

    Rome, Italy
    October 13-14, 2025

    8th International Conference on Anti-Cancer Drugs & Therapies

    Aix-en-Provence, France
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain
    November 24-25, 2025

    43rd World Cancer Conference

    Barcelona, Spain

    Gene Editing & CRISPR in Cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in